Benutzer: Gast  Login
Titel:

Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper.

Dokumenttyp:
Journal Article; Article
Autor(en):
Pfaar, O; Bastl, K; Berger, U; Buters, J; Calderon, M A; Clot, B; Darsow, U; Demoly, P; Durham, S R; Galán, C; Gehrig, R; Gerth van Wijk, R; Jacobsen, L; Klimek, L; Sofiev, M; Thibaudon, M; Bergmann, K C
Abstract:
Clinical efficacy of pollen allergen immunotherapy (AIT) has been broadly documented in randomized controlled trials. The underlying clinical endpoints are analysed in seasonal time periods predefined based on the background pollen concentration. However, any validated or generally accepted definition from academia or regulatory authorities for this relevant pollen exposure intensity or period of time (season) is currently not available. Therefore, this Task Force initiative of the European Acad...     »
Zeitschriftentitel:
Allergy
Jahr:
2017
Band / Volume:
72
Heft / Issue:
5
Seitenangaben Beitrag:
713-722
Sprache:
eng
Volltext / DOI:
doi:10.1111/all.13092
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/27874202
Print-ISSN:
0105-4538
TUM Einrichtung:
Klinik und Poliklinik für Dermatologie und Allergologie; Molekulare Allergologie (Prof. Schmidt-Weber)
 BibTeX